Patent ID: 6071884
Filing Date: 2000-06-06
Classification: A61K,A61P,C07H

Abstract:
A method for the treatment of thrombocytopenia, wherein an effective amount of at least one .alpha.-galactosylceramide represented by the formula (A) is administered to a patient in need of inhibition of a reduction in number of blood platelets or an increase in number of blood platelets: ##STR28## wherein R.sub.2 represents H or OH, X is an integer of 0-26 or R represents --(CH.sub.2).sub.7 CH.dbd.CH(CH.sub.2).sub.7 CH.sub.3, and R.sub.1, is a substituent defined by the following (a) to (d):(a) --CH.sub.2 (CH.sub.2).sub.Y CH.sub.3,(b) --CH(OH)(CH.sub.2).sub.Y CH.sub.3,(c) --CH(OH)(CH.sub.2).sub.Y CH(CH.sub.3).sub.2, or(d) --CH.dbd.(CH)(CH.sub.2).sub.Y CH.sub.3wherein Y is an integer of 5-17.